From the forums · Question 29 of 35

Red, itchy or bruised injection site

Local reactions are common with tirzepatide and uncommon with semaglutide. Most are minor. A few signs separate a skin reaction from an allergic reaction.

By Dr. Chiranjeevi Peetla · Updated November 2026 · 3 min read · 2 sources, each linked

Why this page exists: this question comes up often in GLP-1 patient forums but rarely in search results. We sampled forum threads by title; we did not quote or identify any user.

What the labels report

On Wegovy, 1.4% had injection-site reactions (itching, redness, inflammation, hardening, irritation) against 1% on placebo.[1] On Zepbound it was 6%, 8% and 8% at 5, 10 and 15 mg, against 2%, including bruising, redness, itching, pain and rash. Hypersensitivity reactions of any kind were 5% versus 3% on Zepbound.[2]

Wegovy 2.4 mg
1.4%
1% placebo
Zepbound 10 mg
8%
2% placebo
Zepbound 15 mg
8%
2% placebo

Share with injection-site reactions, drug vs placebo.[1][2]

What the labels say about sites

Both labels list the abdomen, thigh and upper arm as injection areas and say to rotate sites with each dose.[1][2] How to inject is something the prescriber or pharmacist should show you; this page is not a how-to.

Signs of an allergic reaction

  • Swelling of the face, lips, tongue or throat
  • Trouble breathing or swallowing
  • Severe rash or itching over the body, a very fast heartbeat, fainting

These are the signs of a serious allergic reaction listed in the label, and need emergency care.[1] A spreading, hot, painful area with fever is a reason to be checked for infection.

The short version

Short on the way. A 35-second captioned version of this page is in production for the Fewer Bites channel. It will be embedded here when it is live.

Questions to bring to your prescriber

Print these or screenshot them. They are conversation starters, not a checklist of things to do.

  • Can you or the pharmacist watch me inject once to check my technique?
  • Is this reaction the kind that settles, or should we look at it?

Education, not advice. This page explains what trials, labels and guidelines report. It does not tell anyone to start, change or stop a medicine. Your prescriber knows your history; this page does not.

Sources

Every number on this page traces to one of these. "Primary read" means the full paper or label was read; "abstract only" means only the abstract was available; "secondary" means the figure was taken from a named review.

  1. Novo Nordisk / FDA. Wegovy (semaglutide) injection and tablets, prescribing information, revised 06/2026. label
  2. Eli Lilly / FDA. Zepbound (tirzepatide) prescribing information, revised 08/2026. label

All 35 questions